Abstract

Neoadjuvant chemoradiotherapy is considered as the standard approach for T3-4 M0 rectal cancer, despite that the optimal dose fractionation remains undefined in the elderly. We performed a retrospective analysis in order to compare conventional (C) and hypofractionated (HF) schedule in elderly patients, in terms of survival and morbidity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call